Czy psychodeliki staną się lekami?
Kosmos August 8, 2024 Peer reviewed DOI: 10.36921/kos.2024_2999 via OpenAlex
Summary
Psychedelics have gained renewed interest for treating depression and addiction, with historical research dating back to the 1950s and 1960s. After being outlawed in the 1970s, studies have resumed in the 21st century, exploring their therapeutic mechanisms and associated risks. The publication also anticipates the emergence of a new medical field focused on classic psychedelics and their analogs.
Study at a glance
| Key finding | The publication discusses the resurgence of research into psychedelics' medical potential and predicts the development of a new branch of medicine based on their use. |
|---|
Abstract
In the past decade, there has been a surge of interest in the therapeutic use of psychedelics, especially in the treatment of depression and addiction, resulting in many new research projects on their properties. This publication outlines the history of scientific experiments conducted with psychedelics in the 1950s and 1960s, as well as their subsequent international outlawing in the 1970s and the resurgence of research into their medical potential with the onset of the 21st century. Additionally, it discusses the potential mechanisms responsible for their therapeutic impact, the dangers accompanying their use, and changes in their legal status in some countries. The text also makes predictions about the development of a new branch of medicine based on the use of classic psychedelics and their new analogs.